| Mr Christopher Glenn Schwizer, PA-C | |
|
325 Princeton Ave, Princeton, NJ 08540-1617 | |
| (609) 924-8131 | |
| Not Available |
| Full Name | Mr Christopher Glenn Schwizer |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 14 Years |
| Location | 325 Princeton Ave, Princeton, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326355702 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bon Secours Mary Immaculate Hospital | Newport news, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedic Surgery And Sports Med Specialist Of Hampton Rds Pc | 8123014784 | 23 |
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced that it was awarded four Therapeutic Discovery Project (TDP) grants, totaling $977,917, by the United States Internal Revenue Service (IRS) as part of the Patient Protection and Affordable Care Act of 2010.
Researchers at Hospital for Special Surgery have been awarded a $100,000 grant from the National Football League (NFL) Charities to research the use of platelet-rich plasma (PRP) and stem cells as treatments for tendon injury and degeneration. For years, PRP has been used to improve healing in various sports injuries, but there is little evidence of its efficacy.
As California State Assembly Bill 95 (Koretz, D-West Hollywood), designed to reign in drug marketing costs in California by requiring manufacturers of drugs for life-threatening chronic conditions to pay the state a rebate equal to the drug marketing cost, moves to the Assembly Appropriations Committee, AIDS Healthcare Foundation (AHF) - cites a study and accompanying editorial published today in the Journal of American Medical Association (JAMA) that demonstrates the influence that Direct to Consumer Advertising (DTCA) has on physicians' prescribing decisions.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced results of preclinical studies, which suggest that pimavanserin, ACADIA's proprietary product candidate currently in Phase III development for Parkinson's disease psychosis, also may have therapeutic benefits in the treatment of Alzheimer's disease psychosis (ADP).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Christopher Glenn Schwizer, PA-C 325 Princeton Ave, Princeton, NJ 08540-1617 Ph: (609) 924-8131 | Mr Christopher Glenn Schwizer, PA-C 325 Princeton Ave, Princeton, NJ 08540-1617 Ph: (609) 924-8131 |
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced that it was awarded four Therapeutic Discovery Project (TDP) grants, totaling $977,917, by the United States Internal Revenue Service (IRS) as part of the Patient Protection and Affordable Care Act of 2010.
Researchers at Hospital for Special Surgery have been awarded a $100,000 grant from the National Football League (NFL) Charities to research the use of platelet-rich plasma (PRP) and stem cells as treatments for tendon injury and degeneration. For years, PRP has been used to improve healing in various sports injuries, but there is little evidence of its efficacy.
As California State Assembly Bill 95 (Koretz, D-West Hollywood), designed to reign in drug marketing costs in California by requiring manufacturers of drugs for life-threatening chronic conditions to pay the state a rebate equal to the drug marketing cost, moves to the Assembly Appropriations Committee, AIDS Healthcare Foundation (AHF) - cites a study and accompanying editorial published today in the Journal of American Medical Association (JAMA) that demonstrates the influence that Direct to Consumer Advertising (DTCA) has on physicians' prescribing decisions.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced results of preclinical studies, which suggest that pimavanserin, ACADIA's proprietary product candidate currently in Phase III development for Parkinson's disease psychosis, also may have therapeutic benefits in the treatment of Alzheimer's disease psychosis (ADP).
› Verified 5 days ago
Marcelle S. Zebuhr, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 325 Princeton Ave, Princeton, NJ 08540 Phone: 609-924-8131 Fax: 609-683-7559 | |
Priya Patel, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 613 Executive Dr, Princeton, NJ 08540 Phone: 908-922-6625 | |
Sweta Goradia, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 253 Witherspoon Street, Princeton, NJ 08540 Phone: 609-497-3000 Fax: 609-683-6807 | |
Mr. Joseph Harold Thornton, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: Princeton University Health, Mccosh Health Center, Princeton, NJ 08544 Phone: 609-258-3141 Fax: 609-258-1355 | |
Shraddha S Patel, Physician Assistant Medicare: Medicare Enrolled Practice Location: 29 Goldstar Dr, Princeton, NJ 08540 Phone: 908-458-7185 | |
Matthew Stephen Engle, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 325 Princeton Ave, Princeton, NJ 08540 Phone: 609-924-8131 Fax: 609-924-8532 | |
Christine Lynch, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 325 Princeton Ave, Princeton, NJ 08540 Phone: 609-924-8131 Fax: 609-924-8532 |